(Q24202288)

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Dexamethasone in adults with bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Dexamethasone therapy for bacterial meningitis: Better never than late?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Role of dexamethasone in neonatal meningitis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Dexamethasone and bacterial meningitis in Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Bacterial meningitis; a review of 356 cases with special reference to corticosteroid and antiserum treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Dexamethasone as an adjunctive treatment of bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Increase in serum osmolality is possible mechanism for the beneficial effects of glycerol in childhood bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Dexamethasone therapy for bacterial meningitis in children: 2- versus 4-day regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Corticosteroid administration and outcome of adolescents and adults with acute bacterial meningitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Eight hundred and seventy-five cases of bacterial meningitis. Part I of a three-part series: clinical data, prognosis, and the role of specialised hospital departments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

The role of dexamethasone in the treatment of bacterial meningitis - a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Genetic variation in GLCCI1 and dexamethasone in bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Dexamethasone and long-term survival in bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

An evidence based approach to individualising treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Hearing loss in adults surviving pneumococcal meningitis is associated with otitis and pneumococcal serotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Adjunctive dexamethasone in adults with meningococcal meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Factors influencing the anti-inflammatory effect of dexamethasone therapy in experimental pneumococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Effect of vaccines on bacterial meningitis worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Acute bacterial meningitis in children presenting to the Royal Liverpool Children's Hospital, Liverpool, UK and the Queen Elizabeth Central Hospital in Blantyre, Malawi: a world of difference

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Dexamethasone for adult community-acquired bacterial meningitis: 20 years of experience in daily practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Dexamethasone treatment for acute bacterial meningitis: how strong is the evidence for routine use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Clinical features and prognostic factors in adults with bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Community-acquired bacterial meningitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Dexamethasone in adults with community-acquired bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Adjunctive dexamethasone therapy for bacterial meningitis in adults: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Evaluation of vancomycin for therapy of adult pneumococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Dexamethasone and long-term outcome in adults with bacterial meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Corticosteroids for acute bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Corticosteroids for acute bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Corticosteroids for acute bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Antibiotic treatment delay and outcome in acute bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

Treatment of pneumococcic meningitis; results when penicillin was used alone compared with those when penicillin and streptomycin were used together, with and without hydrocortisone: alternate patient studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

7 January 2021

Trial of dexamethasone treatment for severe bacterial meningitis in adults. Adult Meningitis Steroid Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

7 January 2021

Lack of effectiveness of dexamethasone in neonatal bacterial meningitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

7 January 2021

Adjunctive dexamethasone in meningitis: does value depend on clinical setting?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

7 January 2021

Long-term beneficial effects of dexamethasone on intellectual and neuropsychological outcome of children with pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

7 January 2021

Community-acquired bacterial meningitis in adults: categorization of causes and timing of death

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

7 January 2021

Cognitive Impairment in Adults with Good Recovery after Bacterial Meningitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

7 January 2021

Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

7 January 2021

Dexamethasone treatment for bacterial meningitis in children and adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

7 January 2021

Outcomes of bacterial meningitis in children: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

7 January 2021

Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

7 January 2021

Beneficial effects of dexamethasone in children with pneumococcal meningitis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

7 January 2021

Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

7 January 2021

Dexamethasone and Pneumococcal Meningitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004405.PUB4

7 January 2021

10.1002/14651858.CD004405.PUB4

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

23733364

1 reference

Consolidated OpenCitations Corpus – April 2017